Total Payments
$2,135
2023 Payments
$205.40
Companies
12
Transactions
33
Medicare Patients
643
Medicare Billing
$54,700
Payment Breakdown by Category
Food & Beverage$2,135 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,135 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $641.68 | 9 | $0 (2023) |
| AbbVie Inc. | $377.34 | 5 | $0 (2023) |
| Gilead Sciences, Inc. | $290.88 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $214.05 | 5 | $0 (2019) |
| PFIZER INC. | $211.52 | 2 | $0 (2019) |
| Sanofi Pasteur Inc. | $130.05 | 2 | $0 (2018) |
| Nestle HealthCare Nutrition Inc. | $81.90 | 1 | $0 (2022) |
| Novo Nordisk Inc | $73.68 | 1 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $47.62 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $30.26 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $205.40 | 3 | AbbVie Inc. ($100.39) |
| 2022 | $216.84 | 3 | Janssen Pharmaceuticals, Inc ($134.94) |
| 2021 | $181.12 | 2 | Janssen Pharmaceuticals, Inc ($106.01) |
| 2020 | $16.22 | 1 | AbbVie Inc. ($16.22) |
| 2019 | $683.05 | 9 | Janssen Pharmaceuticals, Inc ($142.24) |
| 2018 | $254.79 | 4 | Gilead Sciences, Inc. ($170.08) |
| 2017 | $577.17 | 11 | Janssen Pharmaceuticals, Inc ($171.44) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $87.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $100.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $94.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $81.90 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $106.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $75.11 | General |
| 01/25/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $104.20 | General |
| Category: Immunology | ||||||
| 11/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $93.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2019 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $89.53 | General |
| Category: VACCINE | ||||||
| 08/23/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/16/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.80 | General |
| 06/17/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $47.62 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 03/27/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $73.68 | General |
| Category: Diabetes | ||||||
| 02/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $79.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $111.17 | General |
| Category: HCV | ||||||
| 07/25/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Respiratory | ||||||
| 04/11/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $58.91 | General |
| 01/17/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $70.02 | General |
| Category: VACCINES | ||||||
| 12/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $69.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $118.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $81.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 88 | 125 | $14,689 | $5,979 |
| 2022 | 2 | 185 | 295 | $70,851 | $13,041 |
| 2021 | 4 | 200 | 356 | $78,984 | $23,396 |
| 2020 | 3 | 170 | 233 | $50,588 | $12,284 |
Total Patients
643
Total Services
1,009
Medicare Billing
$54,700
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 65 | 99 | $11,087 | $4,224 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 26 | $3,602 | $1,755 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 89 | 172 | $40,055 | $7,884 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 79 | $18,188 | $2,681 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 28 | $8,056 | $1,780 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 16 | $4,552 | $696.26 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 265 | $59,011 | $16,284 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 52 | $14,095 | $3,846 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $5,562 | $3,121 | 56.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 12 | 15 | $316.10 | $145.65 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 142 | $30,491 | $7,048 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 33 | $8,756 | $2,749 | 31.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 21 | $2,797 | $855.31 | 30.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 23 | $4,876 | $830.57 | 17.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 14 | 14 | $3,668 | $800.86 | 21.8% |
About Dr. William Swords, DO
Dr. William Swords, DO is a Sports Medicine healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992982631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Swords, DO has received a total of $2,135 in payments from pharmaceutical and medical device companies, with $205.40 received in 2023. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,135).
As a Medicare-enrolled provider, Swords has provided services to 643 Medicare beneficiaries, totaling 1,009 services with total Medicare billing of $54,700. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Lansing, MI
- Active Since 01/24/2008
- Last Updated 12/13/2013
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1992982631
Products in Payments
- XARELTO (Drug) $641.68
- ELIQUIS (Drug) $229.17
- FLUZONE HIGH-DOSE (Drug) $130.05
- Epclusa (Drug) $111.17
- JANUVIA (Drug) $106.68
- Rinvoq (Biological) $104.20
- SKYRIZI (Biological) $100.39
- GARDASIL (Biological) $89.53
- ZENPEP (Drug) $81.90
- Ozempic (Drug) $73.68
- OPSUMIT (Drug) $47.62
- SYMBICORT (Drug) $30.26
- PNEUMOVAX 23 (Biological) $17.84
- CREON (Drug) $16.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.